This group further demonstrated that acetylated tau was associated with the formation of insoluble tau NFTs in tau transgenic mice and human tauopathies indicating “acetylation” as a pathogenic post-translational modification of tau (Cohen et al., 2011). The gene discussed is MAPT; the disease is tauopathy.